Furthermore, the increased levels of p53 protein associated with its mutation are associated with the production of anti-p53 autoantibodies, reinforcing the potential role of p53 in regulating tumor antigenicity (Couch et al., 2007; Garziera et al., 2015). Here, TP53 is linked to neoplasm.